TABLE 3.
Distribution of 18F-rhPSMA-7–Avid Lesions Stratified by PSA Value
| Metastatic site |
||||||
| PSA value (ng/mL) | Local recurrence | Pelvic lymph nodes | Retroperitoneal lymph nodes | Supradiaphragmatic lymph nodes | Bone | Viscera |
| <0.2 | 4/22 (18%) | 3/22 (13.6%) | 0/22 (0%) | 0/22 (0%) | 2/22 (9.1%) | 0/22 (0%) |
| 0.2–<0.5 | 27/59 (46%) | 13/59 (22.0%) | 4/59 (6.8%) | 0/59 (0%) | 7/59 (12%) | 0/59 (0%) |
| 0.5–<1 | 21/51 (41%) | 19/51 (37.3) | 4/51 (7.8%) | 1/51 (2.0%) | 11/51 (22%) | 3/51 (5.9%) |
| 1–<2 | 22/49 (45%) | 24/49 (49.0%) | 8/49 (16%) | 4/49 (8.2%) | 8/49 (16%) | 1/49 (2.0%) |
| ≥2 | 39/80 (49%) | 51/80 (63.8%) | 29/80 (36%) | 16/80 (20.0%) | 26/80 (33%) | 6/80 (7.5%) |
| All patients | 113/261 (43%) | 110/261 (42%) | 45/261 (17%) | 21/261 (8%) | 54/261 (21%) | 10/261 (4%) |